Genotype associations of factor VII gene with plasma factor VII coagulant activity and antigen levels in healthy Chinese

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 3, 2002, Pages 217-224

  Liu, Yanqun ^a   Heng, C K ^a   Saha, N ^a   Hong, S ^a   Low, P S ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Antigen level; Chinese; Coagulant activity; Coronary heart disease; Factor VII; Polymorphism

Indexed keywords

BLOOD CLOTTING FACTOR 7; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BINDING SITE; BLOOD CLOTTING; CHIMERA; CHINESE; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ADULT; AGED; ALLELES; AMINO ACID SUBSTITUTION; ANTIGENS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DNA MUTATIONAL ANALYSIS; FACTOR VII; FACTOR VII DEFICIENCY; FACTOR VIIA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MUTATION, MISSENSE; POINT MUTATION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REFERENCE VALUES; SINGAPORE;

EID: 0036526214     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200204000-00007     Document Type: Article

References (39)

1. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
2. Factor VII activity and ischaemic heart disease: Fatal and non-fatal events
3. Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese
4. Coagulation factor VII and the risk of coronary heart disease in healthy men
5. Elevation of factor VII activity and mass in coronary artery disease of varying severity
6. Coronary artery disease and factor VII hyperactivity in elderly Japanese
7. A novel form of factor VII in plasma from men at risk for cardiovascular disease
8. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: A clinical and laboratory study
9. Fibrinogen, factor VII clotting activity and coronary artery disease severity
10. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study
11. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study
12. Activated factor VII: Presence in factor IX concentrates and persistence in the circulation after infusion
13. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population - II. Baseline data on the relation to age, gender, bodyweight, smoking, alcohol, pill-using, and menopause
14. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration
15. The PLAT study: A multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients
16. Hypertriglyceridaemia and hypercoagulability
17. The activation of the contact phase of coagulation by physiologic surfaces in plasma: The effect of large negatively charged liposomal vesicles
18. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals
19. Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease
20. 353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study
21. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine353 variant
22. Association of factor VII genotype with plasma factor VII activity and antigen levels in healthy Indian adults and interaction with triglycerides
23. Genetic determinants of plasma factor VII activity in the Japanese
24. Genetic polymorphism (Arg353 → Gln) in coagulation factor VII gene and factor VII levels (coagulant activity, antigen and binding ability to tissue factor) in 101 healthy Japanese
25. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age: Role of plasma lipoproteins and factor VII genotype
26. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma
27. Factor VII polymorphisms in populations with different risks of cardiovascular disease
28. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction
29. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease
30. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. I. Differences in mortality
31. Coronary heart disease in south Asians overseas: A review
32. Coronary artery disease in Asians
33. Racial variation of factor VII activity and antigen levels and their correlates in healthy Chinese and Indians at low and high risk for coronary artery disease
34. A rapid method for the isolation of genomic DNA from citrated whole blood
35. Nonuniform recombination within the human β-globin gene cluster
36. Functional characterization of the human factor VII 5′-flanking region
37. 353Gln polymorphism reduces the level of coagulation factor VII
38. Genetic modulation of coagulation factor VII plasma levels: Contribution of different polymorphisms and gender-related effects
39. Association of factor VII:C levels with environmental and genetic factors in patients with ischaemic heart disease and coronary atheroma characterised by angiography